Eli Lilly, Walmart to offer discounted retail option for Zepbound
The post Eli Lilly, Walmart to offer discounted retail option for Zepbound appeared on BitcoinEthereumNews.com.
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty Images Eli Lilly and Walmart on Wednesday said they have teamed up to expand access to the drugmaker’s weight loss drug Zepbound, allowing U.S. patients to get vials of the blockbuster injection at direct-to-consumer prices through retail locations for the first time. The announcement comes as Eli Lilly works to maintain its dominance over rival Novo Nordisk in the booming market for a class of obesity and diabetes drugs called GLP-1s. It also comes as the Trump administration pressures drugmakers to make it easier for Americans to access medicines with a push for them to use direct-to-consumer models that eliminate middlemen. Starting in mid-November, cash-paying patients with a prescription can purchase single-dose vials of Zepbound at discounts of 50% or more off their list price through the retailer’s locations or via home delivery. Walmart, which operates nearly 4,600 pharmacies across the U.S., will serve as the first in-store pickup pharmacy option for Zepbound vials through Eli Lilly’s direct-to-consumer cash-pay platform, LillyDirect. It is LillyDirect’s first retail collaboration since it launched in January 2024, following partnerships with several telehealth companies. Eli Lilly did not provide an estimate of how much the Walmart offering will expand Zepbound’s reach. But Walmart’s nationwide footprint makes it the largest U.S. retailer, LillyDirect’s General Manager Jennifer Mazur told CNBC in an interview. Walmart is the fifth-largest pharmacy in the U.S., according to its total prescription dispensing revenue in 2024. The partnership could help Eli Lilly keep its competitive edge over Novo Nordisk as the Danish drugmaker works to expand access to its weight loss drug Wegovy through a deal with CVS and its pharmacy benefit manager, Caremark. Single-dose vials of Zepbound…
Filed under: News - @ October 29, 2025 6:29 pm